Acrivon Therapeutics, Inc. 8-K

Accession 0000950170-24-059097

Filing information

CIK: 0001781174
Report date: 2024-05-14
Filing date: 2024-05-14
Form: 8-K
Primary document: acrv-20240514.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.